Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.

The oncologist - 1 Nov 2021

Harrison Rebecca A, Sharafeldin Noha, Rexer Jennie L, Streck Brennan, Petersen Melissa, Henneghan Ashley M, Kesler Shelli R

Abstract excerpt

Hematopoietic stem cell transplant (HSCT) plays a central role in the treatment of hematologic cancers. With the increasing survival of patients after HSCT, survivorship issues experienced by this population have become an important outcome. Cognitive impairment is an established sequela of HSCT, with studies to date establishing its presence, associated risk factors, and clinical phenotype. There are multiple...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Hematologic Neoplasms
Share to Hematopoietic Stem Cell Transplantation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Quality of Life

Source

Open in PubMed Open full text

Identifiers

PMID: 34156729
DOI: 10.1002/onco.13867
PMCID: PMC8571768

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurocognitive Impairment After Hematopoietic Stem Cell Transplant for Hematologic Malignancies: Phenotype and Mechanisms.PMID 34156729Read ↗

Cognitive Changes Related to Cancer Therapy.Semantic proximity Read ↗

Clinical and Genetic Risk Prediction of Cognitive Impairment After Blood or Marrow Transplantation for Hematologic Malignancy.Semantic proximity Read ↗

A Systematic Review Focusing on Understanding the Effects of a Defined Set of Non-Modifiable Factors in Patients who Suffer from Chemotherapy Induced Cognitive Impairments or “Chemobrain”Semantic proximity Read ↗

Effect of cancer therapy on neural stem cellsSemantic proximity Read ↗

Prevalence of cancer-related cognitive impairment in pediatric patients and survivors of non-CNS cancers: A systematic review and meta-analysisSemantic proximity Read ↗

Cognitive phenotypes: Unraveling the heterogeneity in cognitive dysfunction among patients with primary brain tumors receiving radiotherapy.Semantic proximity Read ↗

Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficienciesSemantic proximity Read ↗

Genome-wide variants and polygenic risk scores for cognitive impairment following blood or marrow transplantation.Semantic proximity Read ↗

Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral AdrenoleukodystrophySemantic proximity Read ↗

Behavioral and Biologic Characteristics of Cancer-related Cognitive Impairment BiotypesSemantic proximity Read ↗

Using neurocognitive phenotypes to inform interventions for adult survivors of childhood cancer.Semantic proximity Read ↗

Cognitive effects of cytotoxic cancer chemotherapy: predisposing risk factors and potential treatments.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.